North Tyneside General Hospital is a district general hospital located on Rake Lane in North Shields, Tyne and Wear. It is managed by Northumbria Healthcare NHS Foundation Trust.

During the past decade, North Tyneside General Hospital conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 15 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 11 clinical trials were completed. i.e. 84.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Tyneside General Hospital" #1 sponsor was "Shire" with 6 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Northumbria Healthcare NHS Foundation Trust" with 3 trials sponsored and "Bayer" with 3 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Tyneside General Hospital" #1 collaborator was "Cancer Research UK" with 2 trials as a collaborator, "Northumbria Healthcare NHS Foundation Trust" with 2 trials as a collaborator, "Solasia Pharma K.K." with 2 trials as a collaborator, "Takeda" with 2 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "North Tyneside General Hospital" are "Colorectal Cancer" (6 trials), "Crohn's Disease" (4 trials), "Ulcerative Colitis" (3 trials), "Arthritis, Psoriatic" (2 trials) and "Breast Cancer" (2 trials). Many other conditions were trialed in "North Tyneside General Hospital" in a lesser frequency.

Most popular intervention types in "North Tyneside General Hospital" are "Drug" (31 trials), "Other" (11 trials), "Biological" (5 trials), "Procedure" (5 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Ontamalimab" (4 trials), "fluorouracil" (3 trials), "quality-of-life assessment" (3 trials) and "BAY1817080" (2 trials). Other intervention names were less common.

The vast majority of trials in "North Tyneside General Hospital" are 43 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "North Tyneside General Hospital". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 24 completed trials in North Tyneside General Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in North Tyneside General Hospital, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".